- Home
- WLK vs BAX Comparison
WLK vs BAX Comparison
Compare WLK & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLK
- BAX
- Stock Information
- Founded
- WLK 1986
- BAX 1931
- Country
- WLK United States
- BAX United States
- Employees
- WLK N/A
- BAX N/A
- Industry
- WLK Major Chemicals
- BAX Medical/Dental Instruments
- Sector
- WLK Industrials
- BAX Health Care
- Exchange
- WLK Nasdaq
- BAX Nasdaq
- Market Cap
- WLK 11.5B
- BAX 12.4B
- IPO Year
- WLK 2004
- BAX N/A
- Fundamental
- Price
- WLK $82.32
- BAX $22.74
- Analyst Decision
- WLK Buy
- BAX Hold
- Analyst Count
- WLK 15
- BAX 9
- Target Price
- WLK $96.27
- BAX $30.78
- AVG Volume (30 Days)
- WLK 1.1M
- BAX 6.2M
- Earning Date
- WLK 11-04-2025
- BAX 11-07-2025
- Dividend Yield
- WLK 2.58%
- BAX 2.99%
- EPS Growth
- WLK N/A
- BAX N/A
- EPS
- WLK N/A
- BAX N/A
- Revenue
- WLK $11,759,000,000.00
- BAX $10,887,000,000.00
- Revenue This Year
- WLK N/A
- BAX $7.39
- Revenue Next Year
- WLK $5.40
- BAX $3.79
- P/E Ratio
- WLK N/A
- BAX N/A
- Revenue Growth
- WLK N/A
- BAX 3.60
- 52 Week Low
- WLK $68.55
- BAX $21.33
- 52 Week High
- WLK $144.95
- BAX $38.29
- Technical
- Relative Strength Index (RSI)
- WLK 45.92
- BAX 43.14
- Support Level
- WLK $79.50
- BAX $21.59
- Resistance Level
- WLK $83.48
- BAX $24.27
- Average True Range (ATR)
- WLK 2.45
- BAX 0.60
- MACD
- WLK 0.06
- BAX 0.11
- Stochastic Oscillator
- WLK 48.31
- BAX 41.50
About WLK Westlake Corporation
Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.